NCT05893108View on ClinicalTrials.gov

Ethosomal Gel Bearing Losartan 5% for Keloid Treatment

PHASE1/PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

March 30, 2024

Primary Completion Date

September 30, 2024

Study Completion Date

October 30, 2024

Conditions
Keloid
Interventions
DRUG

Ethosomal gel bearing losartan 5%

A pharmaceutical company with a good manufacturing practice certificate is developing ethosomal gel bearing losartan 5%

DRUG

triamcinolone acetonide 10 mg/ml

intralesional injection

Trial Locations (1)

Unknown

Rumah Sakit Syafira, Pekanbaru

All Listed Sponsors
collaborator

Gadjah Mada University

OTHER

lead

Yuni Eka Anggraini

OTHER

NCT05893108 - Ethosomal Gel Bearing Losartan 5% for Keloid Treatment | Biotech Hunter | Biotech Hunter